Skip to main content

Articles

Page 286 of 335

  1. Activating transcription factor-3 (ATF3) is involved in the complex process of cellular stress response. However, its exact role in cancer is discussed controversially because both tumor suppressive and oncoge...

    Authors: Christina Hackl, Sven A Lang, Christian Moser, Akira Mori, Stefan Fichtner-Feigl, Claus Hellerbrand, Wolfgang Dietmeier, Hans J Schlitt, Edward K Geissler and Oliver Stoeltzing
    Citation: BMC Cancer 2010 10:668
  2. The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has been described for various solid tumors and their clinical relevance has been shown. CTC detection based on the anal...

    Authors: Eva Obermayr, Fatima Sanchez-Cabo, Muy-Kheng M Tea, Christian F Singer, Michael Krainer, Michael B Fischer, Jalid Sehouli, Alexander Reinthaller, Reinhard Horvat, Georg Heinze, Dan Tong and Robert Zeillinger
    Citation: BMC Cancer 2010 10:666
  3. The internet portal http://​www.​brustkrebs-studien.​de (BKS) was launched in 2000 by the German Society of Senology (DGS) and the Baden-Württemberg Insti...

    Authors: Markus Wallwiener, Christian W Wallwiener, Sara Y Brucker, Andreas D Hartkopf, Tanja N Fehm and Julia K Kansy
    Citation: BMC Cancer 2010 10:663
  4. Accurate staging of colorectal cancer (CRC) with clinicopathological parameters is important for predicting prognosis and guiding treatment but provides no information about organ site of metastases. Patterns ...

    Authors: Sjoerd C Bruin, Christiaan Klijn, Gerrit-Jan Liefers, Linde M Braaf, Simon A Joosse, Eric H van Beers, Victor J Verwaal, Hans Morreau, Lodewyk F Wessels, Marie-Louise F van Velthuysen, Rob AEM Tollenaar and Laura J van't Veer
    Citation: BMC Cancer 2010 10:662
  5. Boron neutron capture therapy (BNCT) is an alternative treatment modality for patients with glioma. The aim of this study was to determine whether induction of apoptosis contributes to the main therapeutic eff...

    Authors: Peng Wang, Haining Zhen, Xinbiao Jiang, Wei Zhang, Xin Cheng, Geng Guo, Xinggang Mao and Xiang Zhang
    Citation: BMC Cancer 2010 10:661
  6. Epidermal growth factor receptor inhibitor therapy is now approved for treatment of metastatic colorectal carcinomas (CRC) in patients with tumors lacking KRAS mutations. Several procedures to detect KRAS mutatio...

    Authors: Magnus Sundström, Karolina Edlund, Monica Lindell, Bengt Glimelius, Helgi Birgisson, Patrick Micke and Johan Botling
    Citation: BMC Cancer 2010 10:660
  7. Angiogenesis is important in the growth and metastasis of various kinds of solid tumors, including gastric cancers. The angiogenic process is triggered by several key growth factors, including vascular endothe...

    Authors: Shioto Suzuki, Yoh Dobashi, Yayoi Hatakeyama, Ryosuke Tajiri, Takashi Fujimura, Carl H Heldin and Akishi Ooi
    Citation: BMC Cancer 2010 10:659
  8. Preliminary studies suggest that physical exercise interventions can improve physical fitness, fatigue and quality of life in cancer patients after completion of chemotherapy. Additional research is needed to ...

    Authors: Caroline S Kampshoff, Laurien M Buffart, Goof Schep, Willem van Mechelen, Johannes Brug and Mai JM Chinapaw
    Citation: BMC Cancer 2010 10:658
  9. Coiled-coil domain containing 115 (Ccdc115) or coiled coil protein-1 (ccp1) was previously identified as a downstream gene of Fibroblast Growth Factor 2 (FGF2) highly expressed in embryonic and adult brain. Ho...

    Authors: Francesca Pellicano, Rachel E Thomson, Gareth J Inman and Tomoko Iwata
    Citation: BMC Cancer 2010 10:657
  10. the study was designed to determine how tumour hormone receptor status affects the subsequent pattern over time (dynamics) of breast cancer recurrence and death following conservative primary breast cancer res...

    Authors: Romano Demicheli, Ilaria Ardoino, Patrizia Boracchi, Danila Coradini, Roberto Agresti, Cristina Ferraris, Massimiliano Gennaro, William JM Hrushesky and Elia Biganzoli
    Citation: BMC Cancer 2010 10:656
  11. The five-year survival rates for head and neck squamous cell carcinoma (HNSCC) patients are less than 50%, and the prognosis has not improved, despite advancements in standard multi-modality therapies. Hence m...

    Authors: Muzafar A Macha, Ajay Matta, SS Chauhan, KW Michael Siu and Ranju Ralhan
    Citation: BMC Cancer 2010 10:655
  12. Basal-like breast cancers (BLBC) are aggressive breast cancers for which, so far, no targeted therapy is available because they typically lack expression of hormone receptors and HER2. Phenotypic features of B...

    Authors: Henne Holstege, Hugo M Horlings, Arno Velds, Anita Langerød, Anne-Lise Børresen-Dale, Marc J van de Vijver, Petra M Nederlof and Jos Jonkers
    Citation: BMC Cancer 2010 10:654
  13. Microarray gene-profiling of invasive breast cancer has identified different subtypes including luminal A, luminal B, HER2-overexpressing and basal-like groups. Basal-like invasive breast cancer is associated ...

    Authors: Wenjing Zhou, Karin Jirström, Christine Johansson, Rose-Marie Amini, Carl Blomqvist, Olorunsola Agbaje and Fredrik Wärnberg
    Citation: BMC Cancer 2010 10:653
  14. Transforming growth factor β (TGFβ) receptor signaling is closely associated with the invasion ability of gastric cancer cells. Although Smad signal is a critical integrator of TGFβ receptor signaling transduc...

    Authors: Osamu Shinto, Masakazu Yashiro, Takahiro Toyokawa, Takafumi Nishii, Ryoji Kaizaki, Taro Matsuzaki, Satoru Noda, Naoshi Kubo, Hiroaki Tanaka, Yosuke Doi, Masaichi Ohira, Kazuya Muguruma, Tetsuji Sawada and Kosei Hirakawa
    Citation: BMC Cancer 2010 10:652
  15. Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combi...

    Authors: Gregor Habl, Alexandra D Jensen, Karin Potthoff, Matthias Uhl, Holger Hof, Jacek Hajda, Christian Simon, Jürgen Debus, Robert Krempien and Marc W Münter
    Citation: BMC Cancer 2010 10:651
  16. Human papillomavirus (HPV) infection is a major risk factor for the development of nearly all cases of cervical cancer worldwide. The presence of HPV DNA in cases of esophageal squamous-cell carcinoma (ESCC) h...

    Authors: Donghong Zhang, Qingying Zhang, Li Zhou, Leijun Huo, Yi Zhang, Zhongying Shen and Yi Zhu
    Citation: BMC Cancer 2010 10:650
  17. The DLX gene family encodes for homeobox transcription factors involved in the control of morphogenesis and tissue homeostasis. Their expression can be regulated by Endothelin1 (ET1), a peptide associated with br...

    Authors: Monica Morini, Simonetta Astigiano, Yorick Gitton, Laura Emionite, Valentina Mirisola, Giovanni Levi and Ottavia Barbieri
    Citation: BMC Cancer 2010 10:649
  18. Weight change during chemotherapy is reported to be associated with a worse prognosis in breast cancer patients, both with weight gain and weight loss. However, most studies were conducted prior to the common ...

    Authors: Emilie Thivat, Sophie Thérondel, Olivier Lapirot, Catherine Abrial, Pierre Gimbergues, Emilie Gadéa, Eloïse Planchat, Fabrice Kwiatkowski, Marie A Mouret-Reynier, Philippe Chollet and Xavier Durando
    Citation: BMC Cancer 2010 10:648
  19. uPAR and MMP-9, which play critical roles in tumor cell invasion, migration and angiogenesis, have been shown to be associated with lipid rafts.

    Authors: Hari Raghu, Prasanna Kumar Sodadasu, Rama Rao Malla, Christopher S Gondi, Norman Estes and Jasti S Rao
    Citation: BMC Cancer 2010 10:647
  20. Identification of urinary biomarkers for detection of bladder cancer recurrence would be beneficial to minimize the frequency of cystoscopy. Our objective was to determine the usability of urine content of mRN...

    Authors: Anne Sofie Brems-Eskildsen, Karsten Zieger, Helle Toldbod, Cherie Holcomb, Russell Higuchi, Francisco Mansilla, Pia P Munksgaard, Michael Borre, Torben F Ørntoft and Lars Dyrskjøt
    Citation: BMC Cancer 2010 10:646
  21. Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification aff...

    Authors: Patrizia Mancuso, Angelica Calleri, Pierluigi Antoniotti, Jessica Quarna, Giancarlo Pruneri and Francesco Bertolini
    Citation: BMC Cancer 2010 10:644
  22. Ovarian carcinoma represents about 4% of all cancers diagnosed in women worldwide. Mortality rate is high, over 50%, mainly due to late diagnosis. Currently there are no acceptable screening techniques availab...

    Authors: György Horvath, Håkan Andersson and Gunnar Paulsson
    Citation: BMC Cancer 2010 10:643
  23. The use of chemotherapy regimens with moderate or high risk of febrile neutropenia (defined as having a FN incidence of 10% or more) and the respective incidence and clinical management of FN in breast cancer ...

    Authors: Laetitia Gerlier, Mark Lamotte, Ahmad Awada, André Bosly, Greet Bries, Véronique Cocquyt, Christian Focan, Stéphanie Henry, Yassine Lalami, Jean-Pascal Machiels, Jeroen Mebis, Nicole Straetmans, Didier Verhoeven and Luc Somers
    Citation: BMC Cancer 2010 10:642
  24. Dll4/Notch and Ephrin-B2/EphB4 pathways play critical roles in tumor vessel development and maturation. This study evaluates the efficacy of the inhibition of both signaling pathways, alone and in combination,...

    Authors: Dusan Djokovic, Alexandre Trindade, Joana Gigante, Marina Badenes, Lilliana Silva, Ren Liu, Xiuqing Li, Ming Gong, Valery Krasnoperov, Parkash S Gill and Antonio Duarte
    Citation: BMC Cancer 2010 10:641
  25. Survival time for lung cancer is poor with over 90% of patients dying within five years of diagnosis primarily due to detection at late stage. The main objective of this study was to evaluate Fourier transform...

    Authors: Paul D Lewis, Keir E Lewis, Robin Ghosal, Sion Bayliss, Amanda J Lloyd, John Wills, Ruth Godfrey, Philip Kloer and Luis AJ Mur
    Citation: BMC Cancer 2010 10:640
  26. Conflicting data exist regarding the prognostic and predictive impact of survivin (BIRC5) in breast cancer. We previously reported survivin cytoplasmic-to-nuclear ratio (CNR) as an independent prognostic indic...

    Authors: Elton Rexhepaj, Karin Jirstrom, Darran P O'Connor, Sallyann L O'Brien, Goran Landberg, Michael J Duffy, Donal J Brennan and William M Gallagher
    Citation: BMC Cancer 2010 10:639
  27. Glucocorticoids (GCs) cause apoptosis and cell cycle arrest in lymphoid cells and constitute a central component in the therapy of lymphoid malignancies, most notably childhood acute lymphoblastic leukemia (AL...

    Authors: Michela Carlet, Kristina Janjetovic, Johannes Rainer, Stefan Schmidt, Renate Panzer-Grümayer, Georg Mann, Martina Prelog, Bernhard Meister, Christian Ploner and Reinhard Kofler
    Citation: BMC Cancer 2010 10:638
  28. Stereotactic body radiation therapy (SBRT) administered via a helical tomotherapy (HT) system is an effective modality for treating lung cancer and metastatic liver tumors. Whether SBRT delivered via HT is a f...

    Authors: Chen-Hsi Hsieh, Ming-Chow Wei, Yao-Peng Hsu, Ngot-Swan Chong, Yu-Jen Chen, Sheng-Mou Hsiao, Yen-Ping Hsieh, Li-Ying Wang and Pei-Wei Shueng
    Citation: BMC Cancer 2010 10:637
  29. We have previously shown that a panel of kallikrein markers - total prostate-specific antigen (PSA), free PSA, intact PSA and human kallikrein-related peptidase 2 (hK2) - can predict the outcome of prostate bi...

    Authors: Amine Benchikh, Caroline Savage, Angel Cronin, Gilles Salama, Arnauld Villers, Hans Lilja and Andrew Vickers
    Citation: BMC Cancer 2010 10:635
  30. Rhabdoid Tumors (RTs) are highly aggressive pediatric malignancies with poor prognosis. There are currently no standard or effective treatments for RTs in part because treatments are not designed to specifical...

    Authors: Velasco Cimica, Melissa E Smith, Zhikai Zhang, Deepti Mathur, Sridhar Mani and Ganjam V Kalpana
    Citation: BMC Cancer 2010 10:634
  31. To compare the activity and toxicity of docetaxel/carboplatin (DC) doublet vs single agent docetaxel (D) as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC).

    Authors: Athanasios G Pallis, Sophia Agelaki, Athina Agelidou, Ioannis Varthalitis, Kostas Syrigos, Nikolaos Kentepozidis, Georgia Pavlakou, Athanasios Kotsakis, Emmanouel Kontopodis and Vassilis Georgoulias
    Citation: BMC Cancer 2010 10:633
  32. Non-small-cell lung carcinomas (NSCLCs) exhibit poor prognosis and are usually resistant to conventional chemotherapy. Absence of p21WAF1/CIP1, a cyclin-dependent kinase (cdk) inhibitor, has been linked to dru...

    Authors: Junxia Wei, Jiang Zhao, Min Long, Yuan Han, Xi Wang, Fang Lin, Jihong Ren, Ting He and Huizhong Zhang
    Citation: BMC Cancer 2010 10:632
  33. Advanced biliary tract carcinomas (BTCs) have poor prognosis and limited therapeutic options. Therefore, it is crucial to combine standard therapies with molecular targeting. In this study EGFR, HER2, and thei...

    Authors: Ymera Pignochino, Ivana Sarotto, Caterina Peraldo-Neia, Junia Y Penachioni, Giuliana Cavalloni, Giorgia Migliardi, Laura Casorzo, Giovanna Chiorino, Mauro Risio, Alberto Bardelli, Massimo Aglietta and Francesco Leone
    Citation: BMC Cancer 2010 10:631
  34. The peroxisome proliferator activated receptor (PPAR) subgroup of the nuclear hormone receptor superfamily is activated by a variety of natural and synthetic ligands. PPARs can heterodimerize with retinoid X r...

    Authors: Ji Seung Han and David L Crowe
    Citation: BMC Cancer 2010 10:629
  35. Combining gene expression microarrays and high resolution magic angle spinning magnetic resonance spectroscopy (HR MAS MRS) of the same tissue samples enables comparison of the transcriptional and metabolic pr...

    Authors: Eldrid Borgan, Beathe Sitter, Ole Christian Lingjærde, Hilde Johnsen, Steinar Lundgren, Tone F Bathen, Therese Sørlie, Anne-Lise Børresen-Dale and Ingrid S Gribbestad
    Citation: BMC Cancer 2010 10:628
  36. The simplicity and potential of minimal invasive testing using serum from patients make auto-antibody based biomarkers a very promising tool for use in diagnostics of cancer and auto-immune disease. Although s...

    Authors: René Stempfer, Parvez Syed, Klemens Vierlinger, Rudolf Pichler, Eckart Meese, Petra Leidinger, Nicole Ludwig, Albert Kriegner, Christa Nöhammer and Andreas Weinhäusel
    Citation: BMC Cancer 2010 10:627
  37. Inducible cyclooxgenase-2 (COX-2) is commonly overexpressed in breast tumors and is a target for cancer therapy. Here, we studied the association of COX-2 with breast cancer survival and how this association i...

    Authors: Sharon A Glynn, Robyn L Prueitt, Lisa A Ridnour, Brenda J Boersma, Tiffany M Dorsey, David A Wink, Julie E Goodman, Harris G Yfantis, Dong H Lee and Stefan Ambs
    Citation: BMC Cancer 2010 10:626
  38. Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were ...

    Authors: Robert Griffiths, Michelle Gleeson, Kevin Knopf and Mark Danese
    Citation: BMC Cancer 2010 10:625
  39. Childhood cancer and its treatment have considerable impact on a child's physical and mental wellbeing. Especially long-term administration of chemotherapy and/or radiotherapy impairs physical fitness both dur...

    Authors: Katja I Braam, Elisabeth M van Dijk, Margreet A Veening, Marc B Bierings, Johannes HM Merks, Martha A Grootenhuis, Mai JM Chinapaw, Gerben Sinnema, Tim Takken, Jaap Huisman, Gertjan JL Kaspers and Eline van Dulmen-den Broeder
    Citation: BMC Cancer 2010 10:624
  40. Oral mucosal melanoma (OMM) is a clinically rare disease with poor prognosis. Various treatment methods have been investigated with the aim of improving the prognosis. This study aimed to analyze the data of a...

    Authors: Xi Yang, Guo-xin Ren, Chen-ping Zhang, Guo-yu Zhou, Yong-jie Hu, Wen-jun Yang, Wei Guo, Jiang Li and Lai-ping Zhong
    Citation: BMC Cancer 2010 10:623
  41. The aim of this population-based study was to assess independent prognostic factors in ovarian cancer using relative survival (RS) and to investigate changes in RS rates from 1982 to 2005.

    Authors: Zeinab Hamidou, Sylvain Causeret, Tienhan S Dabakuyo, Julie Gentil, Laurent Arnould, Patrick Roignot, Thierry Altwegg, Marie-Laure Poillot, Franck Bonnetain and Patrick Arveux
    Citation: BMC Cancer 2010 10:622
  42. Adjuvant chemotherapy has been shown to improve survival rates of postoperative patients with non-small cell lung cancer (NSCLC). Biomarkers could help select an appropriate chemotherapy for NSCLC patients or ...

    Authors: Shi Yan, Jiao Shun-Chang, Chen Li, Li Jie, Lv Ya-Li and Wang Ling-Xiong
    Citation: BMC Cancer 2010 10:621
  43. The largest burden of hepatocellular carcinoma (HCC) lies in Asia, secondary to hepatitis B virus (HBV) infection. Improved survival with sorafenib has fostered new research but many challenges remain in desig...

    Authors: Winnie Yeo, Pei-Jer Chen, Junji Furuse, Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, Hanlim Moon, Shukui Qin, Ee-Min Yeoh and Sheng-Long Ye
    Citation: BMC Cancer 2010 10:620
  44. Similar to human breast cancer mammary tumors of the female dog are commonly associated with a fatal outcome due to the development of distant metastases. However, the molecular defects leading to metastasis a...

    Authors: Robert Klopfleisch, Dido Lenze, Michael Hummel and Achim D Gruber
    Citation: BMC Cancer 2010 10:618
  45. Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, TFPI-2 was suggested to be a tumor suppresso...

    Authors: Shumin Wang, Xue Xiao, Xiaoying Zhou, Tingting Huang, Chunping Du, Nana Yu, Yingxi Mo, Longde Lin, Jinyan Zhang, Ning Ma, Mariko Murata, Guangwu Huang and Zhe Zhang
    Citation: BMC Cancer 2010 10:617
  46. MicroRNAs (miRNAs) are endogenously expressed noncoding RNAs with important biological and pathological functions. Although several studies have shown that microRNA-31 (miR-31) is obviously up-regulated in col...

    Authors: Chao-Jie Wang, Johannes Stratmann, Zong-Guang Zhou and Xiao-Feng Sun
    Citation: BMC Cancer 2010 10:616
  47. Treatment standard for patients with atypical or anaplastic meningioma is neurosurgical resection. With this approach, local control ranges between 50% and 70%, depending on resection status. A series or small...

    Authors: Stephanie E Combs, Lutz Edler, Iris Burkholder, Stefan Rieken, Daniel Habermehl, Oliver Jäkel, Thomas Haberer, Andreas Unterberg, Wolfgang Wick, Jürgen Debus and Renate Haselmann
    Citation: BMC Cancer 2010 10:615

Featured videos

View featured videos from across the BMC-series journals